Voyager Therapeutics Inc (VYGR)
8.43
-0.20
(-2.32%)
USD |
NASDAQ |
May 17, 16:00
8.43
0.00 (0.00%)
After-Hours: 20:00
Voyager Therapeutics Free Cash Flow: 8.233M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | 8.233M |
| December 31, 2023 | 74.66M |
| September 30, 2023 | 86.00M |
| June 30, 2023 | 91.35M |
| March 31, 2023 | 73.67M |
| December 31, 2022 | -15.00M |
| September 30, 2022 | 9.025M |
| June 30, 2022 | 4.14M |
| March 31, 2022 | 0.923M |
| December 31, 2021 | -55.13M |
| September 30, 2021 | -91.52M |
| June 30, 2021 | -100.04M |
| March 31, 2021 | -100.18M |
| December 31, 2020 | -108.81M |
| September 30, 2020 | -110.02M |
| June 30, 2020 | -102.88M |
| March 31, 2020 | -113.42M |
| Date | Value |
|---|---|
| December 31, 2019 | 40.95M |
| September 30, 2019 | 42.81M |
| June 30, 2019 | 47.07M |
| March 31, 2019 | 56.86M |
| December 31, 2018 | -20.19M |
| September 30, 2018 | -10.32M |
| June 30, 2018 | -8.119M |
| March 31, 2018 | -1.093M |
| December 31, 2017 | -65.34M |
| September 30, 2017 | -67.30M |
| June 30, 2017 | -61.69M |
| March 31, 2017 | -54.80M |
| December 31, 2016 | -47.51M |
| September 30, 2016 | -40.23M |
| June 30, 2016 | -36.54M |
| March 31, 2016 | -34.12M |
| December 31, 2015 | 40.27M |
Free Cash Flow Range, Past 5 Years
-113.42M
Minimum
Mar 2020
91.35M
Maximum
Jun 2023
-15.91M
Average
2.532M
Median
Free Cash Flow Benchmarks
| Ligand Pharmaceuticals Inc | -19.62M |
| Stereotaxis Inc | -8.683M |
| United Therapeutics Corp | 752.40M |
| MEI Pharma Inc | -43.82M |
| Agios Pharmaceuticals Inc | -318.99M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 58.77M |
| Cash from Investing (Quarterly) | -96.06M |
| Cash from Financing (Quarterly) | 112.86M |
| Free Cash Flow Per Share (Quarterly) | 0.9914 |
| Free Cash Flow to Equity (Quarterly) | 56.63M |
| Free Cash Flow to Firm (Quarterly) | 56.63M |
| Free Cash Flow Yield | 2.00% |